New cancer drug trial begins for patients with advanced tumors
NCT ID NCT07160725
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This early-stage study tests a new drug called BMS-986517 in adults with advanced solid tumors that cannot be removed by surgery or have spread. The main goal is to check the drug's safety and side effects. About 315 participants will receive the drug, and researchers will also look at how well it shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOURS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Copenhagen University Hospital Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
Contact Phone: •••-•••-••••
-
Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
Contact Phone: •••-•••-••••
-
Herlev and Gentofte Hospital
RECRUITINGCopenhagen, Capital Region, 2730, Denmark
Contact Phone: •••-•••-••••
-
Local Institution - 0022
NOT_YET_RECRUITINGBadalona, Barcelona [Barcelona], 08916, Spain
Contact
-
Local Institution - 0023
NOT_YET_RECRUITINGMadrid, 28050, Spain
Contact
-
Local Institution - 0024
NOT_YET_RECRUITINGBarcelona, Barcelona [Barcelona], 08035, Spain
Contact
-
Local Institution - 0025
NOT_YET_RECRUITINGPamplona, Navarre, 31008, Spain
Contact
-
Local Institution - 0026
NOT_YET_RECRUITINGMálaga, Andalusia, 29010, Spain
Contact
-
Local Institution - 0027
NOT_YET_RECRUITINGMadrid, 28040, Spain
Contact
-
Local Institution - 0033
NOT_YET_RECRUITINGIrvine, California, 92612, United States
Contact
-
National Cancer Center Hospital
RECRUITINGChuo-ku, Tokyo, 104-0045, Japan
Contact Phone: •••-•••-••••
-
Odense Universitetshospital
RECRUITINGOdense, Region Syddanmark, 5000, Denmark
Contact Phone: •••-•••-••••
-
START - Dallas Fort Worth
RECRUITINGFort Worth, Texas, 76104, United States
Contact Phone: •••-•••-••••
-
START Mountain Region
RECRUITINGWest Valley City, Utah, 84119, United States
Contact Phone: •••-•••-••••
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Phone: •••-•••-••••
-
Sanford Cancer Center
RECRUITINGSioux Falls, South Dakota, 57104, United States
Contact Phone: •••-•••-••••
-
UPMC Hillman Cancer Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
Contact Phone: •••-•••-••••
-
USC/Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
Contact Phone: •••-•••-••••
-
University of California, Irvine (UCI) Health - UC Irvine Medical Center
RECRUITINGOrange, California, 92868-3201, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.